Namenda

This page shows the latest Namenda news and features for those working in and with pharma, biotech and healthcare.

Forest said to be interested in $3bn Aptalis acquisition

US for former blockbuster antidepressant Lexapro (escitalopram), as well as generic competition from 2015 for Alzheimer's disease therapy Namenda (memantine). ... With Lexapro and Namenda accounting for more than three quarters of company turnover at

Latest news

Lundbeck and Otsuka take Alzheimer's drug into phase III

Regardless, it has been 10 years since the last new Alzheimer's treatment reached the market - Lundbeck's glutamate (NMDA) antagonist Ebixa (memantine), which is sold as Namenda by Forest Labs
Forest's net income down for Q3

He said: "We have been working diligently for the past seven years to build a solid product development pipeline that will more than replace the loss of Lexapro and Namenda following
Forest Laboratories earnings rise

Lexapro (escitalopram) and its Alzheimer's drug Namenda (memantine) lose their patent protection in the coming years. . ... expiration for both Lexapro in 2012 and Namenda in 2015 and provide growth," he said.
Lifting the fog

Additionally, a patch formulation of donepezil is in development. Also approved for the treatment of moderate-to-severe AD is memantine (Namenda, Forest Laboratories), which was the first NMDA receptor antagonist
Forest Labs earnings fall in Q2

revenues lost due to patent expiration for Lexapro in 2012 and [the Alzheimer's drug] Namenda (memantine) in 2015.".

More from news
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest Intelligence

Pharma deals during January 2014

Not disclosed. Adamas. Forest. Completion of studies for the NDA of a fixed dosed combination of Namenda and donepezil, Forest has exclusive US commercialisation rights.
Pharma deals during November 2012

Development / commercialisation. Fixed dose combination of Namenda and donepezil for AD.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Senior Medical Writer: Salary TBC

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

PR Associate Director – Consumer Health & Beauty: Salary TBC

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Account Director, Medical Education: Salary TBC

Director – Healthcare PR: Salary TBC

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

NEW FREELANCE OPPORTUNITIES!!! LONDON and HOME WORKING!: EXCELLENT DAY RATES AVAILABLE

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Senior Medical Writer: Competitive salary and benefits

Editor – Medical Education Agency – Bucks: Salary TBC

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...